Learning outcomes
By the end of this lesson you should be able to: define gestational hypertension, pre-eclampsia, severe pre-eclampsia, eclampsia and HELLP syndrome; describe the pathophysiology of pre-eclampsia and the risk factors that predict it; list the assessment and the investigations of a woman with suspected pre-eclampsia; describe the prevention and the pharmacological management, including magnesium sulfate; describe the definitive treatment and the timing of delivery; and recognise the complications that make pre-eclampsia a cause of maternal death.
Prerequisites
Lessons 7 and 8, and PHYS 102 for the physiology of the vasculature. Pre-eclampsia is a disorder of the placenta's vasculature that expresses itself as disease of the mother's.
The big idea
The definitions are easier to remember if they are read as a sequence of the same disease. Gestational hypertension is the blood pressure alone. Pre-eclampsia is the blood pressure plus an organ that is not working normally. Severe pre-eclampsia is the same disease at a rate that makes it dangerous — a systolic of 160 or a diastolic of 110. And eclampsia is a seizure that the disease has caused, breaking the only rule that had kept the woman safe.
The definitions, in a table
| Term | Definition |
|---|---|
| Gestational hypertension | New-onset hypertension of 140/90 mm Hg or more after 20 weeks of pregnancy, without proteinuria or organ dysfunction, returning to normal by 12 weeks postpartum |
| Pre-eclampsia | New-onset hypertension after 20 weeks with proteinuria of 300 milligrams or more in 24 hours, or a protein to creatinine ratio of 30 milligrams per millimole or more, or any other maternal organ dysfunction |
| Severe pre-eclampsia | Pre-eclampsia with hypertension of 160/110 mm Hg or more, proteinuria of 5 grams or more, or with acute kidney injury, raised transaminases, thrombocytopenia, cerebral or visual symptoms, or pulmonary oedema |
| Eclampsia | The occurrence of generalised tonic-clonic seizures in a woman with pre-eclampsia, in the absence of any other cause |
| HELLP syndrome | Haemolysis, elevated liver enzymes and a low platelet count — a severe variant, often with epigastric or right upper quadrant pain |
NoteProteinuria is no longer required for the diagnosis of pre-eclampsia: hypertension after 20 weeks with either renal, liver, haematological, neurological or uteroplacental involvement is pre-eclampsia, and about a fifth of women with the disease have no urinary protein at all.
Worked example: why pre-eclampsia happens
The disease starts in the first trimester, in the placenta. In a normal pregnancy the cytotrophoblast invades the spiral arteries of the uterus and converts them from small, muscular, high-resistance vessels into large, low-resistance channels that can carry the blood the placenta needs at term. In pre-eclampsia that invasion fails, the arteries remain narrow and high-resistance, and the placenta is perfused at a level it cannot sustain. The ischaemic placenta then releases anti-angiogenic factors, principally soluble fms-like tyrosine kinase 1, that antagonise vascular endothelial growth factor and placental growth factor, and the maternal endothelium — kidney, liver, brain, lungs and the clotting system — stops behaving normally.
| Organ | Consequence of endothelial dysfunction | How it presents |
|---|---|---|
| Kidney | Glomerular endotheliosis reduces filtration and produces proteinuria | Oedema, proteinuria, a rising creatinine and oliguria |
| Liver | Periportal haemorrhage and hepatocellular swelling stretch the liver capsule | Epigastric or right upper quadrant pain, raised transaminases, and HELLP |
| Blood | Platelet activation and haemolysis at the site of fibrin deposition | Thrombocytopenia, haemolysis and disseminated intravascular coagulation |
| Brain | Vasospasm, cerebral oedema and hyperperfusion | Headache, visual disturbance, hyperreflexia with clonus, and in the extreme a seizure |
| Lung | Increased capillary permeability with left ventricular filling pressures that are often normal | Pulmonary oedema, which is the commonest cause of death |
| Placenta | Reduced perfusion and maternal vascular malperfusion | Fetal growth restriction, oligohydramnios, abruption and perinatal death |
Risk factors, prevention and screening
| Risk factors | Why it matters |
|---|---|
| Nulliparity, a first pregnancy by the same partner, and previous pre-eclampsia | The strongest historical risk factor is a previous affected pregnancy, in which the risk rises to about a fifth or more |
| Age of 40 or more, a body mass index of 35 or more | The most modifiable risk factors, and the ones that counselling addresses |
| A family history of pre-eclampsia | A shared genetic susceptibility to the abnormal placentation |
| Multiple pregnancy, and a long interpregnancy interval of more than 10 years | Both represent a large placenta for which the uterine vasculature is not adequately developed |
| Pre-existing hypertension, chronic kidney disease, diabetes, and antiphospholipid syndrome | Pre-existing disease of the vasculature that the pregnancy then reveals |
Prevention is limited but real. A woman with one high-risk or two moderate-risk factors is offered low-dose aspirin of 75 to 150 milligrams daily from 12 weeks to delivery, which reduces pre-eclampsia by about a quarter, and calcium supplementation is advised in populations with a low dietary calcium intake. The rest of the strategy is the blood pressure measured at every antenatal visit, which is why the simple measurement is the most valuable part of the whole antenatal schedule.
Clinical correlation: management
| Problem | Management |
|---|---|
| Control of severe hypertension | Labetalol intravenously first, then oral nifedipine or hydralazine, to bring the blood pressure below 140/90 and prevent a cerebral haemorrhage; angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and atenolol are avoided |
| Prevention and treatment of eclampsia | Magnesium sulfate, 4 grams intravenously over 5 to 10 minutes followed by an infusion of 1 gram per hour for 24 hours after delivery, for eclampsia and for severe pre-eclampsia in labour |
| Definitive treatment | Delivery. At term a woman with pre-eclampsia is delivered; before 34 weeks the pregnancy is often prolonged by days, with antihypertensives and magnesium, for the benefit of the fetus, provided the mother remains stable |
| Fetal lung maturity | Betamethasone before 34+6 weeks where preterm delivery is anticipated |
| Fluid balance | Restricted to about 80 millilitres per hour with careful input-output and daily weights, because pulmonary oedema is the commonest cause of death in this disease |
| Postpartum | Blood pressure and proteinuria are re-checked at 6 to 8 weeks and at 13 weeks postpartum; a woman whose blood pressure has not normalised has chronic hypertension and future cardiovascular risk |
Watch outMagnesium sulfate is monitored clinically: patellar reflexes, respiratory rate above 12 per minute, urine output above 30 millilitres per hour, and the antidote calcium gluconate at hand. Reflexes disappear before respiration fails, and that order is the safeguard.
A woman at 33 weeks has a blood pressure of 170/115 with headache and visual disturbance and the reflexes are brisk with ankle clonus. What is the immediate management?
Common mistakes
Watch outSaying proteinuria is required for the diagnosis. It is a feature, not a criterion: hypertension after 20 weeks with any maternal organ dysfunction is pre-eclampsia, and many women with the disease have no protein in the urine.
Watch outSaying the treatment of pre-eclampsia is the treatment of the blood pressure. The blood pressure is treated to prevent a cerebral haemorrhage, but the disease only resolves after delivery, and the temporising management of the hypertension must not delay delivery in the woman whose mother or fetus is at risk.
Watch outConfusing eclampsia and epilepsy. A seizure in a woman with pre-eclampsia after 20 weeks is eclampsia until proven otherwise, and the management is magnesium and delivery, not antiepileptic drugs.
Check your understanding
What is the definition of pre-eclampsia, and how does it differ from gestational hypertension?
What are the components of HELLP syndrome, and how does it present?
How is magnesium sulfate monitored, and which drug is its antidote?
Multiple choice
Which finding is sufficient, together with hypertension after 20 weeks, to diagnose pre-eclampsia?
Which drug is first line for acute control of severe hypertension in pregnancy?
Which regimen of magnesium sulfate is used to prevent eclampsia?
Which feature is the earliest clinical sign of magnesium toxicity, and which drug is the antidote?
What is the definitive treatment of pre-eclampsia?
Which prophylactic measure is offered to a woman at high risk of pre-eclampsia?
Summary and next
Hypertension arising after 20 weeks is gestational hypertension until an organ is involved, and pre-eclampsia once it is. The disease is a failure of placental spiral artery remodelling that produces maternal endothelial dysfunction, whose clinical extremes are eclampsia, HELLP syndrome and pulmonary oedema, and whose definitive treatment is delivery. The clinical triad is a blood pressure at every visit, aspirin for prevention, and magnesium sulfate with an antihypertensive for the severe disease, with fluids restricted because oedema of the lung kills more women than the seizure does.
Next: preterm labour and the rupture of membranes before term, where the same two instruments — corticosteroids and magnesium — are used, but for a fetus whose survival is at stake rather than a mother whose blood pressure is.